Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.18B |
| 2 |
Apple
AAPL
|
+$1.11B |
| 3 |
Broadcom
AVGO
|
+$562M |
| 4 |
Amazon
AMZN
|
+$553M |
| 5 |
Palo Alto Networks
PANW
|
+$485M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$246M |
| 2 |
O'Reilly Automotive
ORLY
|
+$149M |
| 3 |
Cadence Design Systems
CDNS
|
+$149M |
| 4 |
Synopsys
SNPS
|
+$134M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.24% |
| 2 | Healthcare | 13.33% |
| 3 | Financials | 12.09% |
| 4 | Consumer Discretionary | 10.85% |
| 5 | Industrials | 9.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Omeros
OMER
$909M
| $6.82M | ﹤0.01% |
1,253,711
+621,819
| +98% | +$3.63M |
|
2527
iRadimed
IRMD
$1.17B
| $6.81M | ﹤0.01% |
142,558
+1,251
| +0.9% | +$56.4K |
|
2528
Amneal Pharmaceuticals
AMRX
$6.02B
| $6.8M | ﹤0.01% |
2,194,991
+319,268
| +17% | +$680K |
|
2529
Emergent Biosolutions
EBS
$382M
| $6.79M | ﹤0.01% |
924,484
+28,030
| +3% | +$260K |
|
2530
Carter Bankshares
CARE
$785M
| $6.78M | ﹤0.01% |
458,548
+8,929
| +2% | +$126K |
|
|
ICPT
2531
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $6.78M | ﹤0.01% |
612,967
+13,629
| +2% | +$190K |
|
2532
Esquire Financial Holdings
ESQ
$1.12B
| $6.77M | ﹤0.01% |
148,110
+20,099
| +16% | +$824K |
|
2533
Voyager Therapeutics
VYGR
$181M
| $6.76M | ﹤0.01% |
590,255
+317,000
| +116% | +$3.28M |
|
2534
Inspired Entertainment
INSE
$183M
| $6.76M | ﹤0.01% |
459,356
+17,497
| +4% | +$237K |
|
2535
Summit Therapeutics
SMMT
$10.4B
| $6.73M | ﹤0.01% |
2,679,309
+1,590,328
| +146% | +$2.9M |
|
|
STER
2536
DELISTED
Sterling Check Corp. Common Stock
STER
| $6.72M | ﹤0.01% |
547,717
+31,454
| +6% | +$377K |
|
2537
DMC Global
BOOM
$149M
| $6.7M | ﹤0.01% |
377,449
+15,392
| +4% | +$278K |
|
|
TWOU
2538
DELISTED
2U Inc
TWOU
| $6.69M | ﹤0.01% |
55,366
+2,896
| +6% | +$385K |
|
2539
Commercial Vehicle Group
CVGI
$156M
| $6.69M | ﹤0.01% |
602,666
+294,400
| +96% | +$2.67M |
|
2540
Tiptree Inc
TIPT
$658M
| $6.65M | ﹤0.01% |
443,074
-7,216
| -2% | -$100K |
|
|
ITOS
2541
DELISTED
iTeos Therapeutics
ITOS
| $6.65M | ﹤0.01% |
502,012
+20,773
| +4% | +$296K |
|
2542
Edgewise Therapeutics
EWTX
$4.13B
| $6.64M | ﹤0.01% |
856,212
+80,725
| +10% | +$681K |
|
2543
Ooma
OOMA
$590M
| $6.63M | ﹤0.01% |
442,970
+18,391
| +4% | +$242K |
|
|
MRSN
2544
DELISTED
Mersana Therapeutics
MRSN
| $6.6M | ﹤0.01% |
80,227
+8,273
| +11% | +$1.21M |
|
2545
AerSale
ASLE
$307M
| $6.6M | ﹤0.01% |
448,778
+23,828
| +6% | +$383K |
|
2546
Butterfly Network
BFLY
$2.19B
| $6.59M | ﹤0.01% |
2,864,618
+267,730
| +10% | +$598K |
|
|
STKL
2547
DELISTED
SunOpta
STKL
| $6.56M | ﹤0.01% |
980,391
-3,802
| -0.4% | -$28.6K |
|
2548
Disc Medicine
IRON
$2.93B
| $6.53M | ﹤0.01% |
147,055
+100,017
| +213% | +$3.55M |
|
2549
LivePerson
LPSN
$22.1M
| $6.51M | ﹤0.01% |
96,019
+1,110
| +1% | +$72K |
|
2550
GCM Grosvenor
GCMG
$795M
| $6.51M | ﹤0.01% |
862,992
+26,729
| +3% | +$199K |
|
Similar funds
Geode Capital Management's Q2 2023 Portfolio in Review
As of Q2 2023, Geode Capital Management held 4,889 positions worth $851B, up 11% from $770B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Trading was light in Q2 2023: portfolio turnover was 4.4%. Geode Capital Management opened 83 new positions and exited 132, leaving the 4,889-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q2 2023 buy was Coupang: 4,567,454 shares worth $79.5M.
- Geode Capital Management added most to Microsoft in Q2 2023, an estimated $1.18B increase.
- Geode Capital Management's biggest Q2 2023 reduction was Procter & Gamble, cutting an estimated $246M.
- Geode Capital Management fully exited Evoqua Water Technologies Corp. Common Stock in Q2 2023, selling an estimated $111M.
- Geode Capital Management's ten largest holdings make up 26% of its $851B portfolio in Q2 2023.
- Geode Capital Management opened 83 new positions and closed 132 in Q2 2023.
- Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $851B.
Based on Geode Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.